Sheppard, Mullin, Richter & Hampton LLP

Life Sciences

Scott Liebman is leader of the firm's Life Sciences team and is based in the firm’s New York office.

Scott focuses on complex FDA regulatory, compliance and legal matters affecting global pharmaceutical, biotechnology and medical device manufacturers. He counsels clients on federal and state requirements and develops legal and regulatory strategies to help commercialize their products.

Clients regularly turn to Scott and his team to support product launches; implement corporate integrity agreements; develop comprehensive training and monitor compliance programs; and handle anti-kickback, sampling and off-label investigations. Whether advising executives or training a national sales force, Scott knows that clear, thoughtful communication and practical advice are key to supporting his clients.

He has worked with businesses of all sizes, from small life sciences organizations launching their first product to Fortune 500 companies in the pharmaceutical and medical products/equipment industries. His clients operate worldwide and include Europe- and Asia-based life sciences companies.

Scott is passionate about understanding his clients’ challenges and is committed to learning their businesses inside and out to find solutions. He brings deep technical knowledge along with enthusiasm for his clients’ work to each client relationship.

J.D., Seton Hall University Law School

B.A., Lehigh University